HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Georg Ertl Selected Research

Ventricular Remodeling

3/2015Acute DNase1 treatment improves left ventricular remodeling after myocardial infarction by disruption of free chromatin.
2/2011Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction.
9/2008Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction.
8/2008Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
7/2007High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
1/2007High-dose 17beta-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat.
9/2006Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction.
3/2006Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction.
3/2006Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX.
7/2005Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Georg Ertl Research Topics

Disease

76Heart Failure
01/2022 - 01/2002
59Myocardial Infarction
12/2022 - 01/2002
22Infarction (Infarctions)
10/2020 - 01/2002
18Ventricular Remodeling
03/2015 - 06/2002
17Fabry Disease (Fabry's Disease)
08/2018 - 09/2003
15Cardiomyopathies (Cardiomyopathy)
08/2018 - 09/2003
14Fibrosis (Cirrhosis)
01/2018 - 11/2003
13Coronary Artery Disease (Coronary Atherosclerosis)
12/2022 - 05/2002
11Body Weight (Weight, Body)
01/2013 - 01/2002
11Cardiomegaly (Heart Hypertrophy)
06/2011 - 11/2002
10Left Ventricular Dysfunction
01/2019 - 11/2003
10Inflammation (Inflammations)
09/2015 - 01/2002
9Hypertrophy
12/2009 - 04/2002
8Ischemia
01/2020 - 09/2003
7Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 10/2006
7Cicatrix (Scar)
06/2014 - 03/2002
6Heart Diseases (Heart Disease)
01/2013 - 09/2004
6Atherosclerosis
01/2012 - 01/2004
5Stroke (Strokes)
12/2022 - 01/2017
5Hypertension (High Blood Pressure)
03/2019 - 06/2004
5Systolic Heart Failure
01/2017 - 04/2007
5Myocardial Ischemia (Ischemic Heart Diseases)
07/2013 - 08/2007
5Reperfusion Injury
07/2009 - 03/2002
4Peripheral Arterial Disease
12/2022 - 01/2017
4Vascular Diseases (Vascular Disease)
10/2020 - 01/2004
4Diabetes Mellitus
03/2019 - 05/2007
4Rupture
01/2016 - 01/2012
4Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
04/2014 - 03/2003
3Cognitive Dysfunction
10/2020 - 01/2018
3Disease Progression
01/2020 - 02/2009
3Cardiogenic Shock
01/2019 - 06/2016
3Hemorrhage
01/2019 - 01/2017
3Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2018 - 02/2005
3Amyloidosis
08/2018 - 03/2008
3ST Elevation Myocardial Infarction
10/2017 - 06/2015
3Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
10/2017 - 09/2003
3Myocarditis (Carditis)
09/2015 - 09/2003
3Pathologic Constriction (Stenosis)
06/2007 - 12/2003
2Renal Insufficiency (Renal Failure)
01/2022 - 01/2020
2Brain Infarction
10/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

16salicylhydroxamic acid (SHAM)IBA
01/2014 - 01/2002
13Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2005
10Proteins (Proteins, Gene)FDA Link
01/2015 - 01/2002
10CollagenIBA
09/2014 - 03/2002
9Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
03/2015 - 11/2003
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2022 - 07/2007
7AldosteroneIBA
03/2015 - 11/2003
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2015 - 01/2002
6Estrogens (Estrogen)FDA Link
08/2011 - 03/2005
6CytokinesIBA
09/2008 - 03/2003
6Eplerenone (Inspra)FDA LinkGeneric
04/2008 - 06/2003
5RivaroxabanIBA
12/2022 - 01/2017
5alpha-Galactosidase (Beano)IBA
05/2018 - 01/2013
5EnzymesIBA
03/2015 - 07/2007
5Nitric Oxide Synthase (NO Synthase)IBA
01/2012 - 11/2002
5Messenger RNA (mRNA)IBA
01/2012 - 04/2002
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012 - 11/2002
5Superoxides (Superoxide)IBA
01/2012 - 01/2002
5Atrial Natriuretic Factor (ANF)IBA
08/2008 - 04/2002
5NF-kappa B (NF-kB)IBA
08/2007 - 03/2003
5Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2007 - 01/2002
4Troponin T (Troponin T1)IBA
01/2019 - 09/2015
4DobutamineFDA LinkGeneric
12/2018 - 11/2002
4Brain Natriuretic Peptide (Natrecor)FDA Link
08/2018 - 04/2007
4GalactosidasesIBA
10/2017 - 01/2011
4Natriuretic PeptidesIBA
01/2017 - 09/2004
4Mineralocorticoid Receptor AntagonistsIBA
04/2015 - 06/2003
4Protein Isoforms (Isoforms)IBA
04/2013 - 03/2005
4Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2012 - 01/2002
4erucylphosphocholineIBA
05/2011 - 11/2005
4Angiotensin IIIBA
08/2009 - 01/2002
4Transcription Factors (Transcription Factor)IBA
08/2007 - 09/2004
4Endothelins (Endothelin)IBA
01/2004 - 04/2002
3DiureticsIBA
01/2022 - 06/2006
3Trinitrotoluene (TNT)IBA
08/2018 - 01/2016
3Hydrocortisone (Cortisol)FDA LinkGeneric
01/2016 - 04/2007
3AntibodiesIBA
01/2015 - 07/2007
3SodiumIBA
10/2012 - 04/2007
3N,N-dimethylarginine (asymmetric dimethylarginine)IBA
05/2012 - 11/2005
3Apolipoproteins E (ApoE)IBA
01/2012 - 07/2006
3AutoantibodiesIBA
07/2010 - 07/2007
3Spironolactone (Aldactone)FDA LinkGeneric
12/2009 - 01/2002
3Estradiol (Delestrogen)FDA LinkGeneric
12/2009 - 09/2005
3SaltsIBA
12/2009 - 11/2006
3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2009 - 03/2006
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2008 - 11/2002
3Streptozocin (Streptozotocin)FDA Link
05/2008 - 05/2007
3Estrogen Receptor alphaIBA
03/2008 - 03/2005
3Estrogen Receptor betaIBA
03/2008 - 03/2005
3Creatine Kinase (Creatine Phosphokinase)IBA
06/2006 - 02/2005
3Ventricular MyosinsIBA
09/2005 - 04/2002
2Factor XIII (Coagulation Factor XIII)IBA
10/2020 - 12/2006

Therapy/Procedure

38Therapeutics
01/2022 - 03/2002
7Drug Therapy (Chemotherapy)
01/2022 - 09/2004
7Ligation
01/2014 - 02/2003
6Patient Readmission
01/2022 - 09/2004
6Enzyme Replacement Therapy
03/2015 - 09/2003
4Percutaneous Coronary Intervention
10/2017 - 04/2003
3Micro-Electrical-Mechanical Systems
01/2022 - 11/2018
2Length of Stay
01/2020 - 01/2019